Professor Robert S. Kass received his Ph.D. in Physics from the University of Michigan in 1972. He was appointed Assistant Professor of Physiology at the University of Rochester in 1977. He was recruited to Columbia University in 1995 as Chair of the Department of Pharmacology, promoted to Vice Dean of Research in 2008, and is now the Alumni and Hosack Professor of Molecular Pharmacology and Therapeutics. The Kass lab has focused on the structure and function of ion channels expressed in the heart. Professor Kass has published over 200 papers in refereed journals and is an associate editor of Nature Scientific Reports.

Professor Svetlana Trofimova, MD, PhD is a leading expert in gerontology, ophthalmology, and preventive and anti-aging medicine. She serves as Deputy Director for Scientific and Clinical Work at the St. Petersburg Institute of Bioregulation and Gerontology, Director of the "Tree of Life" Clinic of Predictive Medicine, President of the Russian Society of Anti-Aging Medicine, and Secretary General of the World Society of Preventive, Regenerative and Anti-Aging Medicine (WOCPM). A distinguished scientist and clinician, Prof. Trofimova has authored more than 160 scientific publications and holds six patents in peptide bioregulation. Her research focuses on peptide-based therapies, regenerative medicine, and healthy longevity, with significant contributions to the treatment of age-related and retinal diseases. An internationally recognized speaker, she is a frequent keynote lecturer at global medical congresses and is widely known for her work promoting healthy aging through scientific research, clinical practice, and public education.

Dr. Jingwei Xie received his B.S. (1999) and M.S. (2002) from Nanjing University of Technology, China, and his Ph.D. from the National University of Singapore (2007). He worked as a postdoctoral fellow in the Xia group at Washington University in St. Louis (2007‐2010). He is currently a Professor in the Department of Surgery-Transplant and Holland Regenerative Medicine Program at the University of Nebraska Medical Center (UNMC). He has won several prestigious awards including Most Promising New Invention Award at UNMC (2017), Maurer Scientific Achievement Award (2019), CAB Mid-Career Investigator Award (2020), Distinguished Scientist Award at UNMC (2021), and Innovator of the Year (2024) at UNMC. He was selected as AIMBE Fellow in 2024. His research interests include biomaterials, drug delivery, wound healing, hemostasis, tissue/disease modeling, and regenerative medicine.

Dr. Rainier Nery Mozo is a physician, educator, and healthcare executive from the Philippines with a growing focus on regenerative, genomic, and longevity medicine. He currently serves as President and CEO of Clearbridge Medical Philippines and is actively involved in advancing innovative and precision-based healthcare initiatives in the region. He is trained in Internal Medicine and holds postgraduate studies in Genomic Medicine from the University of South Wales (United Kingdom), with an academic foundation in Biochemistry. Dr. Mozo is also certified in Regenerative Medicine and Cellular Therapeutics through international training programs, with clinical interests centered on stem cells, exosomes, immune-cell therapies, longevity science, and translational regenerative medicine. Beyond clinical and executive work, Dr. Mozo is an Associate Professor at the Pamantasan ng Lungsod ng Maynila College of Medicine, where he teaches Medicine and Medical Research. He is also a co-founder of the Philippine Institute for Regenerative Medicine (PHIRM), an organization dedicated to promoting education, collaboration, and responsible innovation in regenerative and precision medicine. Dr. Mozo continues to advocate for the integration of regenerative medicine, genomics, and preventive healthcare into real-world clinical practice, with the vision of making future-forward medicine more accessible in the Philippines and across Asia.

Dr. Loysa Orense is a medical doctor and stem cell practitioner with extensive expertise in regenerative medicine, CAR-NK cell therapy, and precision medicine. She is an international lecturer on stem cells, CAR-NK cells, and regenerative medicine, and a member of several global scientific organizations, including the International Society for Stem Cell Applications (USA), the Asia Pacific Society on Precision Anti-Aging Medicine (Taiwan), and the International Society for Stem Cell Research (USA). She serves on the Peer Review Committee on Stem Cell Research for Ganesha Medicina Journal (Universitas Pendidikan Ganesha, Indonesia) and is Chairperson of the Academic and Scientific Committee of the Philippine Peptide Society. She holds certifications as a Diplomate in Hospital Leadership and Management and a Certified Hospital Administrator. She is the owner of a patented Artificial Intelligence–SMS Platform recognized by the Intellectual Property Office, Department of Justice. She is the President and CEO of three companies: Ourense Health, a precision medicine center focused on personalized and regenerative therapies; Vireo Loadworks Inc., a technology company that developed the multi-awarded BantAI COVID system used by Quezon City during the COVID-19 pandemic; and Great Valley Trading Corporation, a medical equipment company. She is also a member of the Women Business Council Philippines, an association of leading women CEOs in the country.

Dr. Lidia De Filippis is a Senior R&D Manager with over 25 years of experience in pharmaceutical sciences, specializing in neural stem cell biology, neurotrophins, and CNS drug development. She holds a Master’s degree in Biological Sciences (University of Milan) and a PhD in Molecular and Cell Biology (Open University, UK). Her career spans both academia and industry, including positions at the University of Milano-Bicocca, Rutgers University, Dompè Farmaceutici, and ReNeuron (UK). She has led multiple preclinical CNS research programs and contributed to the development of innovative therapeutics, including intranasal rhBDNF. Dr. De Filippis has authored over 40 peer-reviewed publications in high-impact journals and is actively engaged in translational neuroscience research.

Dr. Hilary Denis Solomons is a medical practitioner and hematology specialist with extensive experience in general practice, pathology, and hospital medicine. He has worked in locum and laboratory positions, including at Biopath Laboratory and Johannesburg General Hospital, and has assisted in gynecological and surgical procedures. He holds a Master of Medicine in Hematology from the University of the Witwatersrand and has authored several publications in hematology, infectious diseases, and cardiovascular medicine. He is fluent in English and Afrikaans and maintains up-to-date professional development accreditation.

Dr. Omid Liaghati, MD, CCFP, CAPM is a licensed Canadian family physician specializing in chronic pain management. He combines medication and interventional techniques in his practice, including nerve blocks, chemical nerve ablation, PRP therapy, stem cell therapy, and phototherapy to provide comprehensive care for patients with persistent pain.

Dr. Sina Farzaneh is a scientist, innovator, and thought leader in regenerative medicine, with over 15 years of experience spanning biomaterials, stem cell biology, platelet research, and translational therapeutics. He currently serves as the Scientific Director of EmCyte Corporation, a global leader in autologous biologic systems, and as a faculty member at the Gulf Coast Biologics Educational and Training Center, while continuing research at the University of Massachusetts Amherst. With over 15 years of experience in tissue engineering, biomaterials, and cellular therapy, he focuses on translating complex science into practical, clinically relevant solutions across musculoskeletal, aesthetic, and wound care applications. An accomplished researcher with 13+ peer-reviewed publications, Dr. Farzaneh also serves as a reviewer for respected scientific journals. He is an international speaker and recognized innovator in regenerative medicine, known for integrating engineering principles with evidence-based biologic therapies to support longevity and performance-focused care.

Dr. Latifa Gaddah is an Immunopathologist and Biotherapies Specialist with advanced expertise in immunogenetics, Biotherapies and high-reliability laboratory systems. With an academic and clinical background, including a Master’s degree in Genetics and specialization in Biotherapies and Doctorate in Medecine. She is international fellow of College of American Pathologists and a regional leader in implementing international standards across advanced diagnostics. She serves as a CAP Inspector Team Leader, AABB International Member and Assessor, and previously ISQua International Fellow, supporting institutions in achieving accreditation’s. Her work spans stem cell processing, cryopreservation, potency assessment, immunogenetics characterization, and cellular therapy quality management. She is Assistant Professor of Immunopathology, Immunogenetics Unit University of Medecine Sussa Tunisia. Dr. Gaddah is also the founder of YLM Training & Consultancy, delivering scientific education and capacity building across the MENA region. Her vision centers on integrating biotherapies, precision immunology, and advanced quality systems to elevate patient safety and deliver transformative clinical outcomes .